|
ANKHD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.33146835171283E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8366419496374E-12 |
| Normal-vs-Stage2 |
1.99247000000069E-05 |
| Normal-vs-Stage3 |
1.77400000023198E-07 |
| Normal-vs-Stage4 |
1.797590E-04 |
| Stage1-vs-Stage2 |
6.468200E-01 |
| Stage1-vs-Stage3 |
2.186600E-01 |
| Stage1-vs-Stage4 |
1.388960E-01 |
| Stage2-vs-Stage3 |
1.979030E-01 |
| Stage2-vs-Stage4 |
1.281820E-01 |
| Stage3-vs-Stage4 |
6.191600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.66133814775094E-16 |
| Normal-vs-AfricanAmerican |
1.840220E-02 |
| Normal-vs-Asian |
1.236430E-02 |
| Caucasian-vs-AfricanAmerican |
5.461700E-02 |
| Caucasian-vs-Asian |
6.217200E-01 |
| AfricanAmerican-vs-Asian |
7.790400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.16064968536512E-12 |
| Normal-vs-Female |
9.47630862668802E-12 |
| Male-vs-Female |
6.944500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.090570E-01 |
| Normal-vs-Age(41-60Yrs) |
2.13229434109508E-12 |
| Normal-vs-Age(61-80Yrs) |
2.46760389899237E-11 |
| Normal-vs-Age(81-100Yrs) |
4.019600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.981700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.942200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.883900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.283400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.310400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.464400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.176900E-03 |
| Normal-vs-Grade 2 |
1.64634972321664E-12 |
| Normal-vs-Grade 3 |
3.02490255066346E-11 |
| Normal-vs-Grade 4 |
2.674400E-02 |
| Grade 1-vs-Grade 2 |
6.562000E-01 |
| Grade 1-vs-Grade 3 |
6.289400E-01 |
| Grade 1-vs-Grade 4 |
4.465500E-02 |
| Grade 2-vs-Grade 3 |
7.806800E-01 |
| Grade 2-vs-Grade 4 |
1.355140E-03 |
| Grade 3-vs-Grade 4 |
3.479200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
3.204300E-03 |
| ccA subtype-vs-ccB subtype |
1.65101265992007E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.86144458022864E-12 |
| Normal-vs-N1 |
2.685600E-01 |
| N0-vs-N1 |
1.751210E-01 |
|
|
